Takeda to Spend $1.7 Billion Next Three Years Buying Drugs From Others
This article was originally published in PharmAsia News
Takeda Pharmaceutical plans to spend about $1.7 billion over the next three years to buy new products from other companies. That amount is in addition to normal expenditures Takeda sets aside annually to purchase drugs made by others. (Click here for more
You may also be interested in...
3D-printing company Carbon and in vitro diagnostics maker Resolution Medical announced plans to manufacture more than one million 3D-printed nasal swabs per week to test for COVID-19. See what Resolution Medical’s president Shawn Patterson said about it here.
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.